1 study found for:    17373905 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer
Condition: Adenocarcinoma
Interventions: Drug: PANVAC-V [Recombinant-Vaccinia-CEA (D609)/MUC-1(L93)/TRICOM];   Drug: PANVAC-F [Recombinant-Fowlpox-CEA (D609)/MUC-1(L93)/TRICOM];   Drug: Leukine (Sargramostim)

Indicates status has not been verified in more than two years